SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-002918
Filing Date
2020-04-27
Accepted
2020-04-27 16:45:15
Documents
13
Period of Report
2020-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_042720.htm 6-K 13656
2 EXHIBIT 99.1 exh_991.htm EX-99.1 18021
3 GRAPHIC exh991_01.jpg GRAPHIC 190840
4 GRAPHIC exh991_02.jpg GRAPHIC 355742
5 GRAPHIC exh991_03.jpg GRAPHIC 182619
6 GRAPHIC exh991_04.jpg GRAPHIC 149247
7 GRAPHIC exh991_05.jpg GRAPHIC 195672
8 GRAPHIC exh991_06.jpg GRAPHIC 273111
9 GRAPHIC exh991_07.jpg GRAPHIC 252854
10 GRAPHIC exh991_08.jpg GRAPHIC 167230
11 GRAPHIC exh991_09.jpg GRAPHIC 203034
12 GRAPHIC exh991_10.jpg GRAPHIC 93579
13 GRAPHIC exh991_11.jpg GRAPHIC 205643
  Complete submission text file 0001171843-20-002918.txt   3157545
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 20820707
SIC: 2834 Pharmaceutical Preparations